NDC 51672-2075-01 - Bacitracin Zinc
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2075
- Requested NDC
- 51672-2075-01
- Package NDCs from labels
- 51672-2075-1, 51672-2075-2, 51672-2075-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-08-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bacitracin Zinc - A-S Medication Solutions | A-S Medication Solutions | 2026-08-07 | HUMAN OTC DRUG LABEL |
| Bacitracin Zinc Ointment USP | Sun Pharmaceutical Industries, Inc. | Sun Pharma Canada Inc. | 2026-04-10 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2075-1 | Bacitracin Zinc | 15 g in 1 TUBE | OINTMENT | 15 | 6 | |
| 51672-2075-1 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 1 in 1 CARTON | OINTMENT | 1 | 6 | |
| 51672-2075-2 | Bacitracin Zinc | 30 g in 1 TUBE | OINTMENT | 30 | 6 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2075 | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 4 | Current NDC, Legacy NDC, 4 package rows | 20241105_4afdeedf-9cdf-47d6-919f-ea907fda0290.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2075-1 | GM - Gram | 51672-2075 | e945b097-4fbc-49ee-be04-cda62ddd0a1b | 1 | 2013-02-13 |
| 51672-2075-2 | GM - Gram | 51672-2075 | 9d1461f6-ec4f-41a4-abbd-699c44ef8cb8 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Bacitracin Zinc | ACTIVE INGREDIENT | 89Y4M234ES | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| Bacitracin | ACTIVE MOIETY | 58H6RWO52I | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| mineral oil | INACTIVE INGREDIENT | T5L8T28FGP | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | BACITRACIN ZINC OINTMENT [TARO PHARMACEUTICALS U.S.A., INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Publix Super Markets Inc | 7b360d3b-fb2b-4f35-a04d-203dd352933d | 2025-08-19 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Good Sense Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | L. Perrigo Company | 2492ee1b-01f1-46e7-8790-b6ebc48f2aff | 2025-08-19 | Warnings | 4T6H12BN9U T5L8T28FGP |
| MedPride Vitamin A and D | WHITE PETROLATUM | Shield Line LLC | 360085ae-29fc-41c9-9875-c902f197a871 | 2025-08-18 | Warnings | 4T6H12BN9U |
| Novita Petrolatum with Cocoa Butter | PETROLATUM | Shield line LLC | 3e9c68e5-8983-1a18-e054-00144ff8d46c | 2025-08-18 | Warnings | 4T6H12BN9U |
| Medpride | WHITE PETROLATUM | Shield Line LLC | 0c4201e1-54f5-4d44-a31a-89aaa511d6b5 | 2025-08-18 | Warnings | 4T6H12BN9U |
| Novita Baby Petrolatum Jelly | PETROLATUM | Shield Line LLC | 3e9cf8bf-929b-45bf-e054-00144ff8d46c | 2025-08-18 | Warnings | 4T6H12BN9U |
| Novita Petrolatum Jelly Pink | PETROLATUM | Shield Line LLC | 3e9d4992-5c1a-16d9-e054-00144ff88e88 | 2025-08-18 | Warnings | 4T6H12BN9U |
| Novita Pure Petrolatum Jelly | PETROLATUM | Shield Line LLC | 3c55614f-932d-4898-e054-00144ff88e88 | 2025-08-18 | Warnings | 4T6H12BN9U |
| Aloe Vera Petrolatum Jelly | PETROLATUM | Shield Line LLC | fdf3b90e-a434-49b2-e053-6394a90ab175 | 2025-08-15 | Warnings | 4T6H12BN9U |
| AmeriDerm Vitamin A D | WHITE PETROLATUM | Shield Line LLC | b73a8fc9-fa00-774a-e053-2995a90afd1e | 2025-08-15 | Warnings | 4T6H12BN9U |
| Baby Petrolatum Jelly | PETROLATUM | SHIELD LINE LLC | 35c163e6-ae41-2791-e054-00144ff8d46c | 2025-08-15 | Warnings | 4T6H12BN9U |
| Natureplex Antibiotic Plus Pain, Itch, Scar Relief | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE, AND PRAMOXINE HYDROCHLORIDE | Natureplex LLC | f0af8829-72fb-46b1-9328-6f4920710bb1 | 2025-08-15 | Warnings | M004 89Y4M234ES |
| PROHEAL TRIPLE ANTIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Nantong Health & Beyond Hygienic Products Inc. | 6c61d88e-4ced-4468-8f99-91652f7a03e4 | 2025-08-13 | Warnings | M004 89Y4M234ES |
| TRIBIOTIC | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | HART Health | c1903b9f-390a-4756-800c-fd93be4182e3 | 2025-08-13 | Warnings, Adverse reactions | 89Y4M234ES |
| DG Health Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Dolgencorp, LLC | d9f12a34-7bd1-4ba5-b34b-1b641f58271a | 2025-08-12 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Stye | MINERAL OIL AND PETROLATUM | Insight Pharmaceuticals LLC | f7eb8466-d8ea-4833-9bed-244ead38a3bf | 2025-08-11 | Warnings | 4T6H12BN9U T5L8T28FGP |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | 4T6H12BN9U |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | J&A Digital Inc. | 9f006f16-083d-4e95-aec2-6ef83405f393 | 2025-08-07 | Warnings | M004 89Y4M234ES |
| Vitacilina First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Taisho Pharmaceutical California Inc. | 93fb9e05-f78c-4d37-b6f1-926cbcb2e7a7 | 2025-08-07 | Warnings | M004 89Y4M234ES |
| SurviveX Triple Antibiotic | TRIPLE ANTIBIOTIC OINTMENT | Nantong Health & Beyond Hygienic Products Inc. | 3bd25bb6-6486-8a0a-e063-6394a90a085c | 2025-08-07 | Warnings | M004 89Y4M234ES |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.